4//SEC Filing
Dananberg Jamie 4
Accession 0000899243-22-038614
CIK 0001463361other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:44 PM ET
Size
5.4 KB
Accession
0000899243-22-038614
Insider Transaction Report
Form 4
Dananberg Jamie
Chief Medical Officer
Transactions
- Sale
Common Stock, $0.0001 par value
2022-12-14$2.85/sh−1,016$2,896→ 65,105 total
Footnotes (3)
- [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- [F2]Includes Restricted Stock Units which vest over time measured from the grant date.
- [F3]Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected by the Issuer on October 19, 2022, which was exempt from reporting pursuant to Rule 16a-9.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001734424
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:44 PM ET
- Size
- 5.4 KB